DVAX has been in the news 1500% more than usual
Dec 24, 2025, 5:31 PM
-0.32%
What does DVAX do
Dynavax Technologies is a biopharmaceutical company based in Emeryville, California, specializing in vaccines and immuno-oncology therapeutics, including the HEPLISAV-B hepatitis B vaccine. The company is developing additional vaccines, including candidates for shingles and Tdap.
DVAX has been in the news recently: Sanofi SA has agreed to acquire Dynavax Technologies for $15.50 per share, amounting to approximately $2.2 billion. Following this announcement, Dynavax's stock surged by 38%.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.